Dose tailoring of anti-tumour necrosis factor-alpha therapy delivers useful clinical efficacy in Crohn disease patients experiencing loss of response
2015 ◽
Vol 74
(Suppl 2)
◽
pp. 1146.1-1146
2018 ◽
Vol 179
(3)
◽
pp. 787-789
◽
2006 ◽
Vol 26
(12)
◽
pp. 1125-1131
◽
2003 ◽
Vol 38
(5)
◽
pp. 522-525
◽
2016 ◽
Vol 11
(1)
◽
pp. 77-83
◽
2010 ◽
Vol 25
(1)
◽
pp. 215-215
◽